Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Shin-Etsu Acquires Drug Delivery Firm
by Jean-François Tremblay
November 12, 2012
| A version of this story appeared in
Volume 90, Issue 46
Shin-Etsu Chemical will spend $13 million to gain a majority stake in NanoCarrier, a Japanese drug delivery technology firm. NanoCarrier is developing drug-encapsulating micellar nanoparticles for use with oncology treatments. The company’s technology is based on research done by two professors at the University of Tokyo and Tokyo Women’s Medical University. Shin-Etsu will inject $8.5 million into NanoCarrier. It will also pay $4.5 million to the private equity firm Whiz Partners to acquire some of Whiz’s shares in NanoCarrier.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter